受强制性开放获取政策约束的文章 - Amod Sarnaik了解详情
无法在其他位置公开访问的文章：1 篇
Current immunotherapy practices in melanoma
LD Rothermel, AA Sarnaik, NI Khushalani, VK Sondak
Surgical Oncology Clinics 28 (3), 403-418, 2019
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：82 篇
Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or-naive melanoma
JS Weber, RR Kudchadkar, B Yu, D Gallenstein, CE Horak, HD Inzunza, ...
Journal of clinical oncology 31 (34), 4311-4318, 2013
强制性开放获取政策： US National Institutes of Health
HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade
DM Woods, AL Sodré, A Villagra, A Sarnaik, EM Sotomayor, J Weber
Cancer immunology research 3 (12), 1375-1385, 2015
强制性开放获取政策： US National Institutes of Health
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
JI Youn, V Kumar, M Collazo, Y Nefedova, T Condamine, P Cheng, ...
Nature immunology 14 (3), 211-220, 2013
强制性开放获取政策： US National Institutes of Health
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
BC Creelan, C Wang, JK Teer, EM Toloza, J Yao, S Kim, AM Landin, ...
Nature medicine 27 (8), 1410-1418, 2021
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Immunotherapy for gastrointestinal malignancies
PG Toomey, NA Vohra, T Ghansah, AA Sarnaik, SA Pilon-Thomas
Cancer Control 20 (1), 32-42, 2013
强制性开放获取政策： US National Institutes of Health
Lifileucel, a tumor-infiltrating lymphocyte therapy, in metastatic melanoma
AA Sarnaik, O Hamid, NI Khushalani, KD Lewis, T Medina, HM Kluger, ...
Journal of Clinical Oncology 39 (24), 2656-2666, 2021
强制性开放获取政策： US National Institutes of Health
Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma
AA Sarnaik, B Yu, D Yu, D Morelli, ML Hall, D Bogle, L Yan, S Targan, ...
Clinical Cancer Research 17 (4), 896-906, 2011
强制性开放获取政策： US National Institutes of Health
Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma
S Pilon-Thomas, L Kuhn, S Ellwanger, W Janssen, E Royster, S Marzban, ...
Journal of immunotherapy 35 (8), 615-620, 2012
强制性开放获取政策： US National Institutes of Health
The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms
KHT Paraiso, HE Haarberg, E Wood, VW Rebecca, YA Chen, Y Xiang, ...
Clinical cancer research 18 (9), 2502-2514, 2012
强制性开放获取政策： US National Institutes of Health
Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
ML Hall, H Liu, M Malafa, B Centeno, PJ Hodul, J Pimiento, ...
Journal for immunotherapy of cancer 4, 1-12, 2016
强制性开放获取政策： US National Institutes of Health
STIM1- and Orai1-mediated Ca2+ oscillation orchestrates invadopodium formation and melanoma invasion
J Sun, F Lu, H He, J Shen, J Messina, R Mathew, D Wang, AA Sarnaik, ...
Journal of Cell Biology 207 (4), 535-548, 2014
强制性开放获取政策： US National Institutes of Health, 国家自然科学基金委员会
Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8+ melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy
JA Chacon, RC Wu, P Sukhumalchandra, JJ Molldrem, A Sarnaik, ...
PloS one 8 (4), e60031, 2013
强制性开放获取政策： US National Institutes of Health
Essential role of HDAC6 in the regulation of PD-L1 in melanoma
M Lienlaf, P Perez-Villarroel, T Knox, M Pabon, E Sahakian, J Powers, ...
Molecular oncology 10 (5), 735-750, 2016
强制性开放获取政策： US National Institutes of Health
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
KV Woan, M Lienlaf, P Perez-Villaroel, C Lee, F Cheng, T Knox, ...
Molecular oncology 9 (7), 1447-1457, 2015
强制性开放获取政策： US National Institutes of Health
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune …
J Chesney, KD Lewis, H Kluger, O Hamid, E Whitman, S Thomas, ...
Journal for immunotherapy of cancer 10 (12), 2022
强制性开放获取政策： US National Institutes of Health
Biomarkers on melanoma patient T cells associated with ipilimumab treatment
W Wang, D Yu, AA Sarnaik, B Yu, M Hall, D Morelli, Y Zhang, X Zhao, ...
Journal of translational medicine 10, 1-12, 2012
强制性开放获取政策： US National Institutes of Health
Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanoma
KN Kodumudi, A Weber, AA Sarnaik, S Pilon-Thomas
The Journal of Immunology 189 (11), 5147-5154, 2012
强制性开放获取政策： US National Institutes of Health
Single-cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases
I Smalley, Z Chen, M Phadke, J Li, X Yu, C Wyatt, B Evernden, JL Messina, ...
Clinical Cancer Research 27 (14), 4109-4125, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
The unique clinical characteristics of melanoma diagnosed in children
D Han, JS Zager, G Han, SS Marzban, CA Puleo, AA Sarnaik, D Reed, ...
Annals of surgical oncology 19, 3888-3895, 2012
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定